Patents by Inventor Mark G. Frei

Mark G. Frei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6768969
    Abstract: A method, computer program, and system for real-time signal analysis providing characterization of temporally-evolving densities and distributions of signal features of arbitrary-type signals in a moving time window by tracking output of order statistic filters (also known as percentile, quantile, or rank-order filters). Given a raw input signal of arbitrary type, origin, or scale, the present invention enables automated quantification and detection of changes in the distribution of any set of quantifiable features of that signal as they occur in time. Furthermore, the present invention's ability to rapidly and accurately detect changes in certain features of an input signal can also enable prediction in cases where the detected changes associated with an increased likelihood of future signal changes.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: July 27, 2004
    Assignee: Flint Hills Scientific, L.L.C.
    Inventors: Alexei V. Nikitin, Mark G. Frei, Naresh C. Bhavaraju, Ivan Osorio
  • Publication number: 20040138711
    Abstract: A method and medical device system for controlling treatment therapy delivered to treat a nervous system disorder. During start-up, the medical device system prevents the therapy device from delivering therapy to the patient for a predetermined time period after the therapy device has been activated. During operation, before the therapy device is programmed, the system performs a check on the programming information to ensure that the programming information will result in treatment therapy being within of an acceptable range of one or more therapy parameters.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 15, 2004
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Mark G. Frei, David L. Carlson
  • Publication number: 20040138517
    Abstract: Apparatuses and methods support multi-modal operation of a medical device system for a nervous system disorder. The medical device system comprises an implanted component and an external component and supports a first feature and a second feature that are associated with the treatment therapy. The medical device system supports both features when the implanted component and the external component are coupled. If the external component is decoupled, the implanted component continues to support the first feature. Moreover, the embodiment may support a plurality of features during a treatment interval. Another aspect of the invention allows for modularly expanding a medical device system in order to add a feature that enhances existing functionality or that provides additional functionality. In an embodiment, a module that is associated with an external component of the medical device system supports the added feature.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 15, 2004
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Mark G. Frei, Mark T. Rise, Scott F. Schaffner, Nina M. Graves
  • Publication number: 20040138721
    Abstract: The present invention uses electrical stimulation of the vagus nerve to treat epilepsy with minimized or no effect on the heart. Treatment is carried out by an implantable signal generator, one or more implantable electrodes for electrically stimulating a predetermined stimulation site of the vagus nerve, and a sensor for sensing characteristics of the heart such as heart rate. The heart rate information from the sensor can be used to determine whether the vagus nerve stimulation is adversely affecting the heart. Once threshold parameters are met, the vagus nerve stimulation may be stopped or adjusted. In an alternative embodiment, the invention may include a modified pacemaker to maintain the heart in desired conditions during the vagus nerve stimulation. In yet another embodiment, the invention may be simply a modified pacemaker having circuitry that determines whether a vagus nerve is being stimulated.
    Type: Application
    Filed: November 13, 2003
    Publication date: July 15, 2004
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Mark G. Frei
  • Publication number: 20040138536
    Abstract: Apparatus and method detect a detection cluster that is associated with a neurological event, such as a seizure, of a nervous system disorder and update therapy parameters that are associated with a treatment therapy. The occurrence of the detection cluster is detected when the maximal ratio exceeds an intensity threshold. If the maximal ratio drops below the intensity threshold for a time interval that is less than a time threshold and subsequently rises above the intensity threshold, the subsequent time duration is considered as being associated with the detection cluster rather than being associated with a different detection cluster. Consequently, treatment of the nervous system disorder during the corresponding time period is in accordance with one detection cluster. Treatment therapy may be provided by providing electrical stimulation, drug infusion or a combination.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 15, 2004
    Applicant: Medtronic, Inc.
    Inventors: Mark G. Frei, Ivan Osorio, Nina M. Graves, Scott F. Schaffner, Mark T. Rise, Jonathon E. Giftakis, David L. Carlson
  • Publication number: 20040138580
    Abstract: Method and apparatus for detecting possible interference in a neurological signal received from a monitoring element of a medical device system. The monitoring element monitors a condition or a symptom of a nervous system disorder being treated and provides a neurological signal to the medical device system for purposes of providing closed-loop feedback control. The system analyzes various parameters of the received signal by taking instantaneous measurements of data points in moving window and thereby determining whether the signal is of poor quality. If the signal is of determined poor quality, it is removed from consideration in the closed-loop feedback control system until it is determined that the signal quality has sufficiently been restored.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 15, 2004
    Applicant: Medtronic, Inc.
    Inventors: Mark G. Frei, Ivan Osorio
  • Publication number: 20040138516
    Abstract: Apparatus and method support the configuration and testing of therapy parameters for a medical device system in the treatment of nervous system disorders. With the embodiment, the medical device system operates in a manual treatment therapy mode, in which the medical device system evaluates a set of information that is indicative of a system configuration. The medical device system determines if the set of information is acceptable. During the manual treatment therapy mode, the medical device system applies therapeutic treatment to a patient in accordance with the set of information. If the patient cannot tolerate the therapeutic treatment, the user indicates so through a user interface. The medical device system may associate the patient's intolerance to therapeutic treatments that equal or exceed the patient's level of tolerance. Moreover, the medical device system may use this information to prevent a delivery of therapeutic treatment that exceeds the patient's level of tolerance during a run mode.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 15, 2004
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Mark G. Frei, Naresh C. Bhavaraju, Thomas E. Peters, Randy M. Jensen
  • Publication number: 20040138581
    Abstract: Method and apparatus for detecting possible interference in a neurological signal received from a monitoring element of a medical device system. The monitoring element monitors a condition or a symptom of a nervous system disorder being treated and provides a neurological signal to the medical device system for purposes of providing closed-loop feedback control. The system analyzes various parameters of the received signal by taking instantaneous measurements of data points in moving window and thereby determining whether the signal is of poor quality. If the signal is of determined poor quality, it is removed from consideration in the closed-loop feedback control system until it is determined that the signal quality has sufficiently been restored.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 15, 2004
    Applicant: Medtronic, Inc.
    Inventors: Mark G. Frei, Ivan Osorio, Johnathan C. Werder, David L. Carlson
  • Publication number: 20040133119
    Abstract: A medical device system capable of scoring a severity of sensed neurological signals relating to a nervous system disorder. The system comprises a monitoring element that receives a neurological signal having at least one event to be scored. The medical device system identifies one or more features of the neurological signal to use in scoring and computes a score of relative severity of the event using the identified feature. Once two or more events have been scored, the events may be ranked by severity relative to each other.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 8, 2004
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Mark G. Frei, Nina M. Graves, Jonathon E. Giftakis
  • Publication number: 20040133248
    Abstract: Apparatuses and methods selectively blank a neurological channel of a medical device system in the treatment of a nervous system disorder. A selected signal of a selected channel may be blanked if it is determined that the selected signal may be affected by an artifact when the medical device system delivers a treatment therapy. The selected signal may be blanked by hardware, in which the selected electrode is disconnected from the selected channel (which may include an selected amplifier) and is connected to a fixed voltage in order to avoid saturation of the selected amplifier. The selected channel may be blanked by software, in which a signal processor is instructed not to process neurological data on the selected channel for a determined time duration. Embodiments may combine hardware and software blanking for the selected signal.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 8, 2004
    Applicant: Medtronic, Inc.
    Inventors: Mark G. Frei, Ivan Osorio, Mark T. Rise, Jonathon E. Giftakis, Nina M. Graves, David L. Carlson, Randy M. Jensen
  • Publication number: 20040133390
    Abstract: Apparatus and method support the synchronization and calibration of a plurality of clocks in a medical device system that may provide treatment to a patient with a nervous system disorder. The plurality of clocks, which may be located at different components of the medical device system, comprises a first clock and a second clock. The second clock may be synchronized to a first clock by disabling a run mode operation and setting the second clock to a selected time. When a reference time of the first clock approximately equals the selected time, the second clock enables the run mode operation. Additionally, a drift time that is indicative of a time difference between the first clock and the second clock is determined. If the drift time is greater than a predetermined amount, an indication to resynchronize the first and second clocks is provided.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 8, 2004
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Naresh C. Bhavaraju, Thomas E. Peters, Mark G. Frei, Jonathan C. Werder
  • Publication number: 20040133120
    Abstract: Method and apparatus for phase shifting neurological signals received from monitoring elements of a medical device. The medical device comprises a plurality of monitoring elements each receiving a neurological signal. The device processes the neurological signals identify a time shift of the neurological signal relative to each other. The neurological signals are then time shifted according to the time shift upon which the signals are utilized to provide closed-loop feedback control of a treatment therapy.
    Type: Application
    Filed: October 15, 2003
    Publication date: July 8, 2004
    Applicant: Medtronic, Inc.
    Inventors: Mark G. Frei, Jonathan C. Werder, David L. Carlson
  • Publication number: 20040078160
    Abstract: A method, computer program, and system for intrinsic timescale decomposition, filtering, and automated analysis of signals of arbitrary origin or timescale including receiving an input signal into a processor, determining a baseline segment and a monotonic residual segment with strictly negative minimum and strictly positive maximum wherein said segments defined on a time interval comprising the interval between two successive extrema of the input signal and wherein the input signal on that interval is the sum of the baseline and residual segments, and producing a baseline output signal and a residual output signal wherein the baseline signal is obtained from the baseline segment and the residual signal is obtained from the residual segment such that the sum of the baseline and residual signals is equal to the input signal thereby forming a decomposition of the input signal.
    Type: Application
    Filed: October 10, 2003
    Publication date: April 22, 2004
    Inventors: Mark G. Frei, Ivan Osorio
  • Patent number: 6671556
    Abstract: The present invention uses electrical stimulation of the vagus nerve to treat epilepsy with minimized or no effect on the heart. Treatment is carried out by an implantable signal generator, one or more implantable electrodes for electrically stimulating a predetermined stimulation site of the vagus nerve, and a sensor for sensing characteristics of the heart such as heart rate. The heart rate information from the sensor can be used to determine whether the vagus nerve stimulation is adversely affecting the heart. Once threshold parameters are met, the vagus nerve stimulation may be stopped or adjusted. In an alternative embodiment, the invention may include a modified pacemaker to maintain the heart in desired conditions during the vagus nerve stimulation. In yet another embodiment, the invention may be simply a modified pacemaker having circuitry that determines whether a vagus nerve is being stimulated.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: December 30, 2003
    Inventors: Ivan Osorio, Mark G. Frei
  • Publication number: 20030195574
    Abstract: The present invention uses electrical stimulation of the vagus nerve to treat epilepsy with minimized or no effect on the heart. Treatment is carried out by an implantable signal generator, one or more implantable electrodes for electrically stimulating a predetermined stimulation site of the vagus nerve, and a sensor for sensing characteristics of the heart such as heart rate. The heart rate information from the sensor can be used to determine whether the vagus nerve stimulation is adversely affecting the heart. Once threshold parameters are met, the vagus nerve stimulation may be stopped or adjusted. In an alternative embodiment, the invention may include a modified pacemaker to maintain the heart in desired conditions during the vagus nerve stimulation. In yet another embodiment, the invention may be simply a modified pacemaker having circuitry that determines whether a vagus nerve is being stimulated.
    Type: Application
    Filed: May 12, 2003
    Publication date: October 16, 2003
    Inventors: Ivan Osorio, Mark G. Frei
  • Publication number: 20030187621
    Abstract: A method, computer program, and system for real-time signal analysis providing characterization of temporally-evolving densities and distributions of signal features of arbitrary-type signals in a moving time window by tracking output of order statistic filters (also known as percentile, quantile, or rank-order filters). Given a raw input signal of arbitrary type, origin, or scale, the present invention enables automated quantification and detection of changes in the distribution of any set of quantifiable features of that signal as they occur in time. Furthermore, the present invention's ability to rapidly and accurately detect changes in certain features of an input signal can also enable prediction in cases where the detected changes associated with an increased likelihood of future signal changes.
    Type: Application
    Filed: April 1, 2003
    Publication date: October 2, 2003
    Inventors: Alexei V. Nikitin, Mark G. Frei, Naresh C. Bhavaraju, Ivan Osorio, Ruslan Davidchack
  • Patent number: 6587727
    Abstract: The present invention uses electrical stimulation of the vagus nerve to treat epilepsy with minimized or no effect on the heart. Treatment is carried out by an implantable signal generator, one or more implantable electrodes for electrically stimulating a predetermined stimulation site of the vagus nerve, and a sensor for sensing characteristics of the heart such as heart rate. The heart rate information from the sensor can be used to determine whether the vagus nerve stimulation is adversely affecting the heart. Once threshold parameters are met, the vagus nerve stimulation may be stopped or adjusted. In an alternative embodiment, the invention may include a modified pacemaker to maintain the heart in desired conditions during the vagus nerve stimulation. In yet another embodiment, the invention may be simply a modified pacemaker having circuitry that determines whether a vagus nerve is being stimulated.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: July 1, 2003
    Inventors: Ivan Osorio, Mark G. Frei
  • Publication number: 20020072776
    Abstract: The present invention uses electrical stimulation of the vagus nerve to treat epilepsy with minimized or no effect on the heart. Treatment is carried out by an implantable signal generator, one or more implantable electrodes for electrically stimulating a predetermined stimulation site of the vagus nerve, and a sensor for sensing characteristics of the heart such as heart rate. The heart rate information from the sensor can be used to determine whether the vagus nerve stimulation is adversely affecting the heart. Once threshold parameters are met, the vagus nerve stimulation may be stopped or adjusted. In an alternative embodiment, the invention may include a modified pacemaker to maintain the heart in desired conditions during the vagus nerve stimulation. In yet another embodiment, the invention may be simply a modified pacemaker having circuitry that determines whether a vagus nerve is being stimulated.
    Type: Application
    Filed: November 9, 2001
    Publication date: June 13, 2002
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Mark G. Frei
  • Publication number: 20020072782
    Abstract: The present invention uses electrical stimulation of the vagus nerve to treat epilepsy with minimized or no effect on the heart. Treatment is carried out by an implantable signal generator, one or more implantable electrodes for electrically stimulating a predetermined stimulation site of the vagus nerve, and a sensor for sensing characteristics of the heart such as heart rate. The heart rate information from the sensor can be used to determine whether the vagus nerve stimulation is adversely affecting the heart. Once threshold parameters are met, the vagus nerve stimulation may be stopped or adjusted. In an alternative embodiment, the invention may include a modified pacemaker to maintain the heart in desired conditions during the vagus nerve stimulation. In yet another embodiment, the invention may be simply a modified pacemaker having circuitry that determines whether a vagus nerve is being stimulated.
    Type: Application
    Filed: November 9, 2001
    Publication date: June 13, 2002
    Applicant: Medtronic, Inc.
    Inventors: Ivan Osorio, Mark G. Frei
  • Patent number: 6341236
    Abstract: A system and method for using electrical stimulation of the vagus nerve to treat epilepsy with minimized or no effect on the heart. Treatment is carried out by an implantable signal generator, one or more implantable electrodes for electrically stimulating a predetermined stimulation site of the vagus nerve, and a sensor for sensing characteristics of the heart such as a heart rate. The heart rate information from the sensor can be used to determine whether the vagus nerve stimulation is adversely affecting the heart. Once threshold parameters are met, the vagus nerve stimulation may be stopped or adjusted. In an alternative embodiment, a modified pacemaker is used to maintain the heart in desired conditions during the vagus nerve stimulation. In yet another embodiment, a modified pacemaker having circuitry that determines whether a vagus nerve is being stimulated is used.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: January 22, 2002
    Inventors: Ivan Osorio, Mark G. Frei